nodes	percent_of_prediction	percent_of_DWPC	metapath
Bethanechol—L-Carnitine—CPT1A—breast cancer	0.0191	0.406	CrCbGaD
Bethanechol—Carbachol—PLA2G4A—breast cancer	0.0177	0.377	CrCbGaD
Bethanechol—L-Carnitine—SLCO1B1—breast cancer	0.0102	0.218	CrCbGaD
Bethanechol—Ill-defined disorder—Anastrozole—breast cancer	0.005	0.0059	CcSEcCtD
Bethanechol—Ill-defined disorder—Letrozole—breast cancer	0.005	0.0059	CcSEcCtD
Bethanechol—Abdominal pain—Lapatinib—breast cancer	0.0049	0.00578	CcSEcCtD
Bethanechol—Malaise—Anastrozole—breast cancer	0.00486	0.00573	CcSEcCtD
Bethanechol—Malaise—Letrozole—breast cancer	0.00486	0.00573	CcSEcCtD
Bethanechol—Hyperhidrosis—Exemestane—breast cancer	0.00479	0.00564	CcSEcCtD
Bethanechol—Lacrimation—Epirubicin—breast cancer	0.00472	0.00557	CcSEcCtD
Bethanechol—Pollakiuria—Goserelin—breast cancer	0.00467	0.00551	CcSEcCtD
Bethanechol—Discomfort—Anastrozole—breast cancer	0.00454	0.00535	CcSEcCtD
Bethanechol—Discomfort—Letrozole—breast cancer	0.00454	0.00535	CcSEcCtD
Bethanechol—Sweating—Tamoxifen—breast cancer	0.00453	0.00534	CcSEcCtD
Bethanechol—Abdominal pain—Fulvestrant—breast cancer	0.00451	0.00531	CcSEcCtD
Bethanechol—Lacrimation increased—Docetaxel—breast cancer	0.00447	0.00526	CcSEcCtD
Bethanechol—Bronchospasm—Vinorelbine—breast cancer	0.00446	0.00525	CcSEcCtD
Bethanechol—Convulsion—Idarubicin—breast cancer	0.00443	0.00523	CcSEcCtD
Bethanechol—Lacrimation—Doxorubicin—breast cancer	0.00437	0.00515	CcSEcCtD
Bethanechol—Hypotension—Ixabepilone—breast cancer	0.00437	0.00515	CcSEcCtD
Bethanechol—Lacrimation increased—Capecitabine—breast cancer	0.00432	0.0051	CcSEcCtD
Bethanechol—Sweating—Goserelin—breast cancer	0.00432	0.0051	CcSEcCtD
Bethanechol—Tachycardia—Letrozole—breast cancer	0.00429	0.00506	CcSEcCtD
Bethanechol—Hyperhidrosis—Letrozole—breast cancer	0.00425	0.00501	CcSEcCtD
Bethanechol—Hyperhidrosis—Anastrozole—breast cancer	0.00425	0.00501	CcSEcCtD
Bethanechol—Diarrhoea—Lapatinib—breast cancer	0.00424	0.005	CcSEcCtD
Bethanechol—Feeling abnormal—Exemestane—breast cancer	0.00408	0.00481	CcSEcCtD
Bethanechol—Hyperhidrosis—Raloxifene—breast cancer	0.00404	0.00476	CcSEcCtD
Bethanechol—Flushing—Tamoxifen—breast cancer	0.00393	0.00464	CcSEcCtD
Bethanechol—Abdominal pain—Exemestane—breast cancer	0.00392	0.00461	CcSEcCtD
Bethanechol—Diarrhoea—Fulvestrant—breast cancer	0.0039	0.0046	CcSEcCtD
Bethanechol—Headache—Lapatinib—breast cancer	0.00388	0.00458	CcSEcCtD
Bethanechol—Flushing—Melphalan—breast cancer	0.00385	0.00454	CcSEcCtD
Bethanechol—Abdominal pain—Ixabepilone—breast cancer	0.00369	0.00435	CcSEcCtD
Bethanechol—Nausea—Lapatinib—breast cancer	0.00368	0.00434	CcSEcCtD
Bethanechol—Feeling abnormal—Anastrozole—breast cancer	0.00363	0.00427	CcSEcCtD
Bethanechol—Feeling abnormal—Letrozole—breast cancer	0.00363	0.00427	CcSEcCtD
Bethanechol—Convulsion—Chlorambucil—breast cancer	0.00359	0.00423	CcSEcCtD
Bethanechol—Bronchospasm—Gemcitabine—breast cancer	0.00358	0.00422	CcSEcCtD
Bethanechol—Headache—Fulvestrant—breast cancer	0.00357	0.00421	CcSEcCtD
Bethanechol—Feeling hot—Epirubicin—breast cancer	0.00354	0.00417	CcSEcCtD
Bethanechol—Headache—Toremifene—breast cancer	0.00353	0.00416	CcSEcCtD
Bethanechol—Ill-defined disorder—Vinblastine—breast cancer	0.00352	0.00415	CcSEcCtD
Bethanechol—Abdominal pain—Letrozole—breast cancer	0.00348	0.0041	CcSEcCtD
Bethanechol—Abdominal pain—Anastrozole—breast cancer	0.00348	0.0041	CcSEcCtD
Bethanechol—Malaise—Vinblastine—breast cancer	0.00343	0.00404	CcSEcCtD
Bethanechol—Diarrhoea—Exemestane—breast cancer	0.00339	0.00399	CcSEcCtD
Bethanechol—Nausea—Fulvestrant—breast cancer	0.00339	0.00399	CcSEcCtD
Bethanechol—Flushing—Vinorelbine—breast cancer	0.00337	0.00397	CcSEcCtD
Bethanechol—Nausea—Toremifene—breast cancer	0.00334	0.00394	CcSEcCtD
Bethanechol—Abdominal pain—Raloxifene—breast cancer	0.0033	0.00389	CcSEcCtD
Bethanechol—Abdominal pain—Idarubicin—breast cancer	0.0033	0.00389	CcSEcCtD
Bethanechol—Convulsion—Vinblastine—breast cancer	0.00329	0.00388	CcSEcCtD
Bethanechol—Feeling hot—Doxorubicin—breast cancer	0.00327	0.00386	CcSEcCtD
Bethanechol—Ill-defined disorder—Goserelin—breast cancer	0.00327	0.00385	CcSEcCtD
Bethanechol—Diarrhoea—Ixabepilone—breast cancer	0.0032	0.00377	CcSEcCtD
Bethanechol—Discomfort—Vinblastine—breast cancer	0.00319	0.00377	CcSEcCtD
Bethanechol—Sweating—Mitoxantrone—breast cancer	0.00319	0.00376	CcSEcCtD
Bethanechol—Sweating—Irinotecan—breast cancer	0.00319	0.00376	CcSEcCtD
Bethanechol—Malaise—Goserelin—breast cancer	0.00318	0.00375	CcSEcCtD
Bethanechol—Convulsion—Melphalan—breast cancer	0.00313	0.00369	CcSEcCtD
Bethanechol—Sweating—Gemcitabine—breast cancer	0.00311	0.00367	CcSEcCtD
Bethanechol—Discomfort—Tamoxifen—breast cancer	0.0031	0.00366	CcSEcCtD
Bethanechol—Headache—Exemestane—breast cancer	0.0031	0.00366	CcSEcCtD
Bethanechol—Convulsion—Goserelin—breast cancer	0.00305	0.0036	CcSEcCtD
Bethanechol—Lacrimation increased—Epirubicin—breast cancer	0.00301	0.00355	CcSEcCtD
Bethanechol—Diarrhoea—Anastrozole—breast cancer	0.00301	0.00355	CcSEcCtD
Bethanechol—Diarrhoea—Letrozole—breast cancer	0.00301	0.00355	CcSEcCtD
Bethanechol—Discomfort—Goserelin—breast cancer	0.00296	0.00349	CcSEcCtD
Bethanechol—Nausea—Exemestane—breast cancer	0.00294	0.00347	CcSEcCtD
Bethanechol—Ill-defined disorder—Vinorelbine—breast cancer	0.00293	0.00345	CcSEcCtD
Bethanechol—Headache—Ixabepilone—breast cancer	0.00293	0.00345	CcSEcCtD
Bethanechol—Hyperhidrosis—Tamoxifen—breast cancer	0.00291	0.00343	CcSEcCtD
Bethanechol—Tachycardia—Melphalan—breast cancer	0.00288	0.00339	CcSEcCtD
Bethanechol—Diarrhoea—Idarubicin—breast cancer	0.00286	0.00337	CcSEcCtD
Bethanechol—Diarrhoea—Raloxifene—breast cancer	0.00286	0.00337	CcSEcCtD
Bethanechol—Malaise—Vinorelbine—breast cancer	0.00285	0.00335	CcSEcCtD
Bethanechol—Pollakiuria—Paclitaxel—breast cancer	0.00281	0.00332	CcSEcCtD
Bethanechol—Tachycardia—Goserelin—breast cancer	0.00281	0.00331	CcSEcCtD
Bethanechol—Lacrimation increased—Doxorubicin—breast cancer	0.00279	0.00329	CcSEcCtD
Bethanechol—Feeling abnormal—Chlorambucil—breast cancer	0.00279	0.00329	CcSEcCtD
Bethanechol—Hyperhidrosis—Goserelin—breast cancer	0.00278	0.00328	CcSEcCtD
Bethanechol—Nausea—Ixabepilone—breast cancer	0.00278	0.00327	CcSEcCtD
Bethanechol—Flushing—Irinotecan—breast cancer	0.00278	0.00327	CcSEcCtD
Bethanechol—Headache—Letrozole—breast cancer	0.00276	0.00325	CcSEcCtD
Bethanechol—Headache—Anastrozole—breast cancer	0.00276	0.00325	CcSEcCtD
Bethanechol—Hypotension—Melphalan—breast cancer	0.00276	0.00325	CcSEcCtD
Bethanechol—Eructation—Epirubicin—breast cancer	0.00273	0.00322	CcSEcCtD
Bethanechol—Salivary hypersecretion—Epirubicin—breast cancer	0.0027	0.00318	CcSEcCtD
Bethanechol—Hypotension—Goserelin—breast cancer	0.00269	0.00317	CcSEcCtD
Bethanechol—Abdominal pain—Chlorambucil—breast cancer	0.00267	0.00315	CcSEcCtD
Bethanechol—Discomfort—Vinorelbine—breast cancer	0.00266	0.00313	CcSEcCtD
Bethanechol—Headache—Idarubicin—breast cancer	0.00262	0.00308	CcSEcCtD
Bethanechol—Headache—Raloxifene—breast cancer	0.00262	0.00308	CcSEcCtD
Bethanechol—Nausea—Letrozole—breast cancer	0.00261	0.00308	CcSEcCtD
Bethanechol—Nausea—Anastrozole—breast cancer	0.00261	0.00308	CcSEcCtD
Bethanechol—Convulsion—Thiotepa—breast cancer	0.00261	0.00308	CcSEcCtD
Bethanechol—Feeling abnormal—Vinblastine—breast cancer	0.00255	0.00301	CcSEcCtD
Bethanechol—Bronchospasm—Docetaxel—breast cancer	0.00254	0.00299	CcSEcCtD
Bethanechol—Eructation—Doxorubicin—breast cancer	0.00252	0.00298	CcSEcCtD
Bethanechol—Tachycardia—Vinorelbine—breast cancer	0.00251	0.00296	CcSEcCtD
Bethanechol—Asthma—Capecitabine—breast cancer	0.0025	0.00295	CcSEcCtD
Bethanechol—Salivary hypersecretion—Doxorubicin—breast cancer	0.0025	0.00294	CcSEcCtD
Bethanechol—Nausea—Idarubicin—breast cancer	0.00248	0.00292	CcSEcCtD
Bethanechol—Nausea—Raloxifene—breast cancer	0.00248	0.00292	CcSEcCtD
Bethanechol—Bronchospasm—Capecitabine—breast cancer	0.00246	0.0029	CcSEcCtD
Bethanechol—Abdominal pain—Vinblastine—breast cancer	0.00245	0.00289	CcSEcCtD
Bethanechol—Ill-defined disorder—Irinotecan—breast cancer	0.00242	0.00285	CcSEcCtD
Bethanechol—Ill-defined disorder—Mitoxantrone—breast cancer	0.00242	0.00285	CcSEcCtD
Bethanechol—Hypotension—Vinorelbine—breast cancer	0.00241	0.00284	CcSEcCtD
Bethanechol—Tachycardia—Thiotepa—breast cancer	0.0024	0.00283	CcSEcCtD
Bethanechol—Abdominal pain—Tamoxifen—breast cancer	0.00238	0.00281	CcSEcCtD
Bethanechol—Feeling abnormal—Goserelin—breast cancer	0.00237	0.00279	CcSEcCtD
Bethanechol—Ill-defined disorder—Gemcitabine—breast cancer	0.00235	0.00277	CcSEcCtD
Bethanechol—Malaise—Mitoxantrone—breast cancer	0.00235	0.00277	CcSEcCtD
Bethanechol—Malaise—Irinotecan—breast cancer	0.00235	0.00277	CcSEcCtD
Bethanechol—Diarrhoea—Chlorambucil—breast cancer	0.00231	0.00273	CcSEcCtD
Bethanechol—Malaise—Gemcitabine—breast cancer	0.00229	0.0027	CcSEcCtD
Bethanechol—Abdominal pain—Goserelin—breast cancer	0.00227	0.00268	CcSEcCtD
Bethanechol—Flushing—Paclitaxel—breast cancer	0.00226	0.00267	CcSEcCtD
Bethanechol—Convulsion—Mitoxantrone—breast cancer	0.00226	0.00266	CcSEcCtD
Bethanechol—Discomfort—Mitoxantrone—breast cancer	0.00219	0.00258	CcSEcCtD
Bethanechol—Discomfort—Irinotecan—breast cancer	0.00219	0.00258	CcSEcCtD
Bethanechol—Convulsion—Fluorouracil—breast cancer	0.00216	0.00255	CcSEcCtD
Bethanechol—Discomfort—Gemcitabine—breast cancer	0.00213	0.00251	CcSEcCtD
Bethanechol—Feeling abnormal—Vinorelbine—breast cancer	0.00212	0.0025	CcSEcCtD
Bethanechol—Diarrhoea—Vinblastine—breast cancer	0.00212	0.0025	CcSEcCtD
Bethanechol—Discomfort—Fluorouracil—breast cancer	0.0021	0.00247	CcSEcCtD
Bethanechol—Tachycardia—Mitoxantrone—breast cancer	0.00207	0.00244	CcSEcCtD
Bethanechol—Diarrhoea—Tamoxifen—breast cancer	0.00206	0.00243	CcSEcCtD
Bethanechol—Hyperhidrosis—Mitoxantrone—breast cancer	0.00205	0.00242	CcSEcCtD
Bethanechol—Hyperhidrosis—Irinotecan—breast cancer	0.00205	0.00242	CcSEcCtD
Bethanechol—Abdominal pain—Vinorelbine—breast cancer	0.00204	0.0024	CcSEcCtD
Bethanechol—Feeling abnormal—Thiotepa—breast cancer	0.00203	0.00239	CcSEcCtD
Bethanechol—Diarrhoea—Melphalan—breast cancer	0.00202	0.00238	CcSEcCtD
Bethanechol—Nausea—Chlorambucil—breast cancer	0.00201	0.00237	CcSEcCtD
Bethanechol—Hyperhidrosis—Gemcitabine—breast cancer	0.002	0.00236	CcSEcCtD
Bethanechol—Tachycardia—Fluorouracil—breast cancer	0.00199	0.00234	CcSEcCtD
Bethanechol—Hypotension—Mitoxantrone—breast cancer	0.00199	0.00234	CcSEcCtD
Bethanechol—Hypotension—Irinotecan—breast cancer	0.00199	0.00234	CcSEcCtD
Bethanechol—Ill-defined disorder—Paclitaxel—breast cancer	0.00197	0.00232	CcSEcCtD
Bethanechol—Diarrhoea—Goserelin—breast cancer	0.00197	0.00232	CcSEcCtD
Bethanechol—Abdominal pain—Thiotepa—breast cancer	0.00194	0.00229	CcSEcCtD
Bethanechol—Headache—Vinblastine—breast cancer	0.00194	0.00229	CcSEcCtD
Bethanechol—Hypotension—Gemcitabine—breast cancer	0.00193	0.00228	CcSEcCtD
Bethanechol—Flushing—Docetaxel—breast cancer	0.00192	0.00226	CcSEcCtD
Bethanechol—Malaise—Paclitaxel—breast cancer	0.00191	0.00226	CcSEcCtD
Bethanechol—Hypotension—Fluorouracil—breast cancer	0.0019	0.00224	CcSEcCtD
Bethanechol—Headache—Tamoxifen—breast cancer	0.00189	0.00222	CcSEcCtD
Bethanechol—Asthma—Methotrexate—breast cancer	0.00186	0.00219	CcSEcCtD
Bethanechol—Flushing—Capecitabine—breast cancer	0.00186	0.00219	CcSEcCtD
Bethanechol—Nausea—Vinblastine—breast cancer	0.00184	0.00217	CcSEcCtD
Bethanechol—Convulsion—Paclitaxel—breast cancer	0.00184	0.00217	CcSEcCtD
Bethanechol—Headache—Goserelin—breast cancer	0.0018	0.00212	CcSEcCtD
Bethanechol—Nausea—Tamoxifen—breast cancer	0.00179	0.00211	CcSEcCtD
Bethanechol—Discomfort—Paclitaxel—breast cancer	0.00179	0.0021	CcSEcCtD
Bethanechol—Diarrhoea—Vinorelbine—breast cancer	0.00176	0.00208	CcSEcCtD
Bethanechol—Nausea—Melphalan—breast cancer	0.00175	0.00206	CcSEcCtD
Bethanechol—Feeling abnormal—Mitoxantrone—breast cancer	0.00175	0.00206	CcSEcCtD
Bethanechol—Feeling abnormal—Irinotecan—breast cancer	0.00175	0.00206	CcSEcCtD
Bethanechol—Asthma—Epirubicin—breast cancer	0.00174	0.00205	CcSEcCtD
Bethanechol—Nausea—Goserelin—breast cancer	0.00171	0.00201	CcSEcCtD
Bethanechol—Feeling abnormal—Gemcitabine—breast cancer	0.00171	0.00201	CcSEcCtD
Bethanechol—Tachycardia—Paclitaxel—breast cancer	0.00169	0.00199	CcSEcCtD
Bethanechol—Diarrhoea—Thiotepa—breast cancer	0.00168	0.00198	CcSEcCtD
Bethanechol—Abdominal pain—Irinotecan—breast cancer	0.00168	0.00198	CcSEcCtD
Bethanechol—Abdominal pain—Mitoxantrone—breast cancer	0.00168	0.00198	CcSEcCtD
Bethanechol—Feeling abnormal—Fluorouracil—breast cancer	0.00168	0.00198	CcSEcCtD
Bethanechol—Hyperhidrosis—Paclitaxel—breast cancer	0.00168	0.00197	CcSEcCtD
Bethanechol—Hypotension—Paclitaxel—breast cancer	0.00162	0.00191	CcSEcCtD
Bethanechol—Ill-defined disorder—Capecitabine—breast cancer	0.00162	0.00191	CcSEcCtD
Bethanechol—Headache—Vinorelbine—breast cancer	0.00161	0.0019	CcSEcCtD
Bethanechol—Asthma—Doxorubicin—breast cancer	0.00161	0.0019	CcSEcCtD
Bethanechol—Pollakiuria—Epirubicin—breast cancer	0.00161	0.0019	CcSEcCtD
Bethanechol—Sweating—Methotrexate—breast cancer	0.00159	0.00188	CcSEcCtD
Bethanechol—Malaise—Capecitabine—breast cancer	0.00157	0.00185	CcSEcCtD
Bethanechol—Convulsion—Docetaxel—breast cancer	0.00156	0.00184	CcSEcCtD
Bethanechol—Headache—Thiotepa—breast cancer	0.00154	0.00182	CcSEcCtD
Bethanechol—Nausea—Vinorelbine—breast cancer	0.00153	0.0018	CcSEcCtD
Bethanechol—Sweating—Epirubicin—breast cancer	0.00149	0.00176	CcSEcCtD
Bethanechol—Pollakiuria—Doxorubicin—breast cancer	0.00149	0.00175	CcSEcCtD
Bethanechol—Discomfort—Capecitabine—breast cancer	0.00147	0.00173	CcSEcCtD
Bethanechol—Nausea—Thiotepa—breast cancer	0.00146	0.00172	CcSEcCtD
Bethanechol—Diarrhoea—Irinotecan—breast cancer	0.00145	0.00171	CcSEcCtD
Bethanechol—Diarrhoea—Mitoxantrone—breast cancer	0.00145	0.00171	CcSEcCtD
Bethanechol—Tachycardia—Docetaxel—breast cancer	0.00143	0.00169	CcSEcCtD
Bethanechol—Feeling abnormal—Paclitaxel—breast cancer	0.00143	0.00168	CcSEcCtD
Bethanechol—Diarrhoea—Gemcitabine—breast cancer	0.00142	0.00167	CcSEcCtD
Bethanechol—Diarrhoea—Fluorouracil—breast cancer	0.00139	0.00164	CcSEcCtD
Bethanechol—Tachycardia—Capecitabine—breast cancer	0.00139	0.00164	CcSEcCtD
Bethanechol—Sweating—Doxorubicin—breast cancer	0.00138	0.00162	CcSEcCtD
Bethanechol—Hyperhidrosis—Capecitabine—breast cancer	0.00137	0.00162	CcSEcCtD
Bethanechol—Hypotension—Docetaxel—breast cancer	0.00137	0.00162	CcSEcCtD
Bethanechol—Abdominal pain—Paclitaxel—breast cancer	0.00137	0.00161	CcSEcCtD
Bethanechol—Headache—Mitoxantrone—breast cancer	0.00133	0.00157	CcSEcCtD
Bethanechol—Headache—Irinotecan—breast cancer	0.00133	0.00157	CcSEcCtD
Bethanechol—Hypotension—Capecitabine—breast cancer	0.00133	0.00157	CcSEcCtD
Bethanechol—Headache—Gemcitabine—breast cancer	0.0013	0.00153	CcSEcCtD
Bethanechol—Flushing—Epirubicin—breast cancer	0.00129	0.00153	CcSEcCtD
Bethanechol—Headache—Fluorouracil—breast cancer	0.00127	0.0015	CcSEcCtD
Bethanechol—Nausea—Mitoxantrone—breast cancer	0.00126	0.00149	CcSEcCtD
Bethanechol—Nausea—Irinotecan—breast cancer	0.00126	0.00149	CcSEcCtD
Bethanechol—Nausea—Gemcitabine—breast cancer	0.00123	0.00145	CcSEcCtD
Bethanechol—Feeling abnormal—Docetaxel—breast cancer	0.00121	0.00143	CcSEcCtD
Bethanechol—Nausea—Fluorouracil—breast cancer	0.00121	0.00142	CcSEcCtD
Bethanechol—Ill-defined disorder—Methotrexate—breast cancer	0.0012	0.00142	CcSEcCtD
Bethanechol—Flushing—Doxorubicin—breast cancer	0.0012	0.00141	CcSEcCtD
Bethanechol—Diarrhoea—Paclitaxel—breast cancer	0.00119	0.0014	CcSEcCtD
Bethanechol—Feeling abnormal—Capecitabine—breast cancer	0.00117	0.00138	CcSEcCtD
Bethanechol—Malaise—Methotrexate—breast cancer	0.00117	0.00138	CcSEcCtD
Bethanechol—Abdominal pain—Docetaxel—breast cancer	0.00116	0.00137	CcSEcCtD
Bethanechol—Ill-defined disorder—Epirubicin—breast cancer	0.00113	0.00133	CcSEcCtD
Bethanechol—Abdominal pain—Capecitabine—breast cancer	0.00112	0.00132	CcSEcCtD
Bethanechol—Convulsion—Methotrexate—breast cancer	0.00112	0.00132	CcSEcCtD
Bethanechol—Malaise—Epirubicin—breast cancer	0.00109	0.00129	CcSEcCtD
Bethanechol—Discomfort—Methotrexate—breast cancer	0.00109	0.00129	CcSEcCtD
Bethanechol—Headache—Paclitaxel—breast cancer	0.00109	0.00128	CcSEcCtD
Bethanechol—Convulsion—Epirubicin—breast cancer	0.00105	0.00124	CcSEcCtD
Bethanechol—Ill-defined disorder—Doxorubicin—breast cancer	0.00104	0.00123	CcSEcCtD
Bethanechol—Nausea—Paclitaxel—breast cancer	0.00103	0.00121	CcSEcCtD
Bethanechol—Hyperhidrosis—Methotrexate—breast cancer	0.00102	0.00121	CcSEcCtD
Bethanechol—Discomfort—Epirubicin—breast cancer	0.00102	0.0012	CcSEcCtD
Bethanechol—Malaise—Doxorubicin—breast cancer	0.00101	0.00119	CcSEcCtD
Bethanechol—Diarrhoea—Docetaxel—breast cancer	0.001	0.00118	CcSEcCtD
Bethanechol—Hypotension—Methotrexate—breast cancer	0.000989	0.00117	CcSEcCtD
Bethanechol—Convulsion—Doxorubicin—breast cancer	0.000973	0.00115	CcSEcCtD
Bethanechol—Diarrhoea—Capecitabine—breast cancer	0.000973	0.00115	CcSEcCtD
Bethanechol—Tachycardia—Epirubicin—breast cancer	0.000967	0.00114	CcSEcCtD
Bethanechol—Hyperhidrosis—Epirubicin—breast cancer	0.000958	0.00113	CcSEcCtD
Bethanechol—Discomfort—Doxorubicin—breast cancer	0.000945	0.00111	CcSEcCtD
Bethanechol—Hypotension—Epirubicin—breast cancer	0.000926	0.00109	CcSEcCtD
Bethanechol—Headache—Docetaxel—breast cancer	0.00092	0.00108	CcSEcCtD
Bethanechol—Tachycardia—Doxorubicin—breast cancer	0.000895	0.00105	CcSEcCtD
Bethanechol—Headache—Capecitabine—breast cancer	0.000891	0.00105	CcSEcCtD
Bethanechol—Hyperhidrosis—Doxorubicin—breast cancer	0.000886	0.00104	CcSEcCtD
Bethanechol—Nausea—Docetaxel—breast cancer	0.000872	0.00103	CcSEcCtD
Bethanechol—Feeling abnormal—Methotrexate—breast cancer	0.000872	0.00103	CcSEcCtD
Bethanechol—Hypotension—Doxorubicin—breast cancer	0.000857	0.00101	CcSEcCtD
Bethanechol—Nausea—Capecitabine—breast cancer	0.000845	0.000996	CcSEcCtD
Bethanechol—Abdominal pain—Methotrexate—breast cancer	0.000837	0.000986	CcSEcCtD
Bethanechol—Feeling abnormal—Epirubicin—breast cancer	0.000816	0.000962	CcSEcCtD
Bethanechol—Abdominal pain—Epirubicin—breast cancer	0.000783	0.000923	CcSEcCtD
Bethanechol—Feeling abnormal—Doxorubicin—breast cancer	0.000755	0.00089	CcSEcCtD
Bethanechol—Abdominal pain—Doxorubicin—breast cancer	0.000725	0.000854	CcSEcCtD
Bethanechol—Diarrhoea—Methotrexate—breast cancer	0.000724	0.000854	CcSEcCtD
Bethanechol—Diarrhoea—Epirubicin—breast cancer	0.000678	0.000799	CcSEcCtD
Bethanechol—Headache—Methotrexate—breast cancer	0.000663	0.000782	CcSEcCtD
Bethanechol—Nausea—Methotrexate—breast cancer	0.000629	0.000741	CcSEcCtD
Bethanechol—Diarrhoea—Doxorubicin—breast cancer	0.000627	0.000739	CcSEcCtD
Bethanechol—Headache—Epirubicin—breast cancer	0.000621	0.000731	CcSEcCtD
Bethanechol—Nausea—Epirubicin—breast cancer	0.000588	0.000694	CcSEcCtD
Bethanechol—Headache—Doxorubicin—breast cancer	0.000574	0.000677	CcSEcCtD
Bethanechol—Nausea—Doxorubicin—breast cancer	0.000544	0.000642	CcSEcCtD
Bethanechol—CHRM3—Metabolism—NCOA1—breast cancer	5.24e-05	0.000501	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—STK11—breast cancer	5.16e-05	0.000494	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP19A1—breast cancer	5.16e-05	0.000494	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FLT1—breast cancer	5.13e-05	0.000491	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGF3—breast cancer	5.11e-05	0.000489	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SQSTM1—breast cancer	5.11e-05	0.000489	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CG—breast cancer	5.08e-05	0.000486	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FLT1—breast cancer	5.08e-05	0.000486	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGF3—breast cancer	5.06e-05	0.000484	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SQSTM1—breast cancer	5.06e-05	0.000484	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—JAG1—breast cancer	5.04e-05	0.000482	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CG—breast cancer	5.03e-05	0.000482	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOTCH3—breast cancer	5.02e-05	0.00048	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PARP1—breast cancer	5.02e-05	0.00048	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—JAG1—breast cancer	4.99e-05	0.000478	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOTCH3—breast cancer	4.97e-05	0.000476	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PARP1—breast cancer	4.97e-05	0.000476	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CALCA—breast cancer	4.96e-05	0.000475	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CALCA—breast cancer	4.91e-05	0.00047	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—RPS6—breast cancer	4.9e-05	0.000469	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGF4—breast cancer	4.86e-05	0.000465	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—RPS6—breast cancer	4.85e-05	0.000464	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CXCR4—breast cancer	4.85e-05	0.000464	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CXCL12—breast cancer	4.85e-05	0.000464	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGF4—breast cancer	4.82e-05	0.000461	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—COMT—breast cancer	4.8e-05	0.000459	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CXCL12—breast cancer	4.8e-05	0.000459	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CXCR4—breast cancer	4.8e-05	0.000459	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GSTP1—breast cancer	4.78e-05	0.000457	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PAK1—breast cancer	4.76e-05	0.000455	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—HMOX1—breast cancer	4.71e-05	0.000451	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PAK1—breast cancer	4.71e-05	0.000451	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ITPR1—breast cancer	4.7e-05	0.00045	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TCF7L2—breast cancer	4.67e-05	0.000447	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AKT2—breast cancer	4.65e-05	0.000445	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TCF7L2—breast cancer	4.63e-05	0.000443	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CG—breast cancer	4.62e-05	0.000442	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AKT2—breast cancer	4.61e-05	0.000441	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CG—breast cancer	4.57e-05	0.000437	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ABCB1—breast cancer	4.52e-05	0.000433	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HSP90AA1—breast cancer	4.5e-05	0.000431	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOTCH2—breast cancer	4.5e-05	0.000431	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CD—breast cancer	4.47e-05	0.000427	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HSP90AA1—breast cancer	4.46e-05	0.000427	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOTCH2—breast cancer	4.46e-05	0.000427	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—TYMS—breast cancer	4.44e-05	0.000425	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CD—breast cancer	4.43e-05	0.000423	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PLA2G4A—breast cancer	4.39e-05	0.00042	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GSTM1—breast cancer	4.39e-05	0.00042	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NCOR1—breast cancer	4.39e-05	0.00042	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AGTR1—breast cancer	4.38e-05	0.000419	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PRL—breast cancer	4.38e-05	0.000419	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AGTR1—breast cancer	4.34e-05	0.000415	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PRL—breast cancer	4.34e-05	0.000415	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—STK11—breast cancer	4.32e-05	0.000413	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ADAM10—breast cancer	4.32e-05	0.000413	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—STK11—breast cancer	4.28e-05	0.000409	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ADAM10—breast cancer	4.28e-05	0.000409	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PLG—breast cancer	4.27e-05	0.000409	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PLG—breast cancer	4.23e-05	0.000405	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AKT2—breast cancer	4.22e-05	0.000404	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—GPX1—breast cancer	4.21e-05	0.000402	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGF10—breast cancer	4.2e-05	0.000402	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AKT2—breast cancer	4.18e-05	0.0004	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CYP1A1—breast cancer	4.16e-05	0.000398	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGF10—breast cancer	4.16e-05	0.000398	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ERCC2—breast cancer	4.13e-05	0.000395	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CD—breast cancer	4.06e-05	0.000388	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PDGFA—breast cancer	4.05e-05	0.000388	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CD—breast cancer	4.02e-05	0.000384	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PDGFA—breast cancer	4.01e-05	0.000384	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFBR2—breast cancer	4e-05	0.000382	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFBR2—breast cancer	3.96e-05	0.000379	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ITPR1—breast cancer	3.93e-05	0.000376	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ERBB4—breast cancer	3.91e-05	0.000374	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—STAT5A—breast cancer	3.91e-05	0.000374	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MMP3—breast cancer	3.91e-05	0.000374	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CB—breast cancer	3.89e-05	0.000373	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ITPR1—breast cancer	3.89e-05	0.000373	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—MTHFR—breast cancer	3.88e-05	0.000371	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—STAT5A—breast cancer	3.87e-05	0.00037	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ERBB4—breast cancer	3.87e-05	0.00037	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MMP3—breast cancer	3.87e-05	0.00037	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CB—breast cancer	3.86e-05	0.000369	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SMAD4—breast cancer	3.78e-05	0.000362	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IGF1R—breast cancer	3.76e-05	0.00036	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SMAD4—breast cancer	3.75e-05	0.000358	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—CXCL8—breast cancer	3.74e-05	0.000358	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IGF1R—breast cancer	3.72e-05	0.000356	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—CXCL8—breast cancer	3.71e-05	0.000355	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HES1—breast cancer	3.69e-05	0.000353	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PLA2G4A—breast cancer	3.67e-05	0.000351	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NCOR1—breast cancer	3.67e-05	0.000351	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HES1—breast cancer	3.66e-05	0.00035	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PLA2G4A—breast cancer	3.64e-05	0.000348	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NCOR1—breast cancer	3.64e-05	0.000348	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CSF2—breast cancer	3.63e-05	0.000347	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGF1—breast cancer	3.63e-05	0.000347	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—RAF1—breast cancer	3.62e-05	0.000347	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NRG1—breast cancer	3.6e-05	0.000345	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CSF2—breast cancer	3.6e-05	0.000344	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGF1—breast cancer	3.6e-05	0.000344	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—RAF1—breast cancer	3.59e-05	0.000343	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—CAV1—breast cancer	3.58e-05	0.000342	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—H2AFX—breast cancer	3.58e-05	0.000342	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—IL2—breast cancer	3.58e-05	0.000342	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NRG1—breast cancer	3.57e-05	0.000341	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—E2F1—breast cancer	3.55e-05	0.00034	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—H2AFX—breast cancer	3.54e-05	0.000339	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—IL2—breast cancer	3.54e-05	0.000339	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CB—breast cancer	3.54e-05	0.000338	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—E2F1—breast cancer	3.52e-05	0.000337	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CB—breast cancer	3.5e-05	0.000335	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SPP1—breast cancer	3.41e-05	0.000327	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—CXCL8—breast cancer	3.4e-05	0.000325	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SPP1—breast cancer	3.38e-05	0.000323	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ERBB3—breast cancer	3.38e-05	0.000323	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGFR2—breast cancer	3.37e-05	0.000323	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—CXCL8—breast cancer	3.37e-05	0.000322	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ERBB3—breast cancer	3.34e-05	0.00032	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGFR2—breast cancer	3.34e-05	0.000319	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CG—breast cancer	3.26e-05	0.000312	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—IL2—breast cancer	3.25e-05	0.000311	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TERT—breast cancer	3.24e-05	0.00031	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—IL2—breast cancer	3.22e-05	0.000308	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TERT—breast cancer	3.2e-05	0.000307	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FGFR1—breast cancer	3.14e-05	0.000301	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FGFR1—breast cancer	3.11e-05	0.000298	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HIF1A—breast cancer	3.1e-05	0.000296	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HIF1A—breast cancer	3.07e-05	0.000293	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—LEP—breast cancer	3.02e-05	0.000289	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CAV1—breast cancer	2.99e-05	0.000286	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—LEP—breast cancer	2.99e-05	0.000286	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CAV1—breast cancer	2.96e-05	0.000284	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—KDR—breast cancer	2.96e-05	0.000283	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—KDR—breast cancer	2.93e-05	0.00028	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ESR1—breast cancer	2.88e-05	0.000276	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CD—breast cancer	2.87e-05	0.000274	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ESR1—breast cancer	2.86e-05	0.000273	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—FN1—breast cancer	2.85e-05	0.000273	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—ALB—breast cancer	2.83e-05	0.000271	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—FN1—breast cancer	2.82e-05	0.00027	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NFKBIA—breast cancer	2.82e-05	0.000269	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOTCH1—breast cancer	2.79e-05	0.000267	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NFKBIA—breast cancer	2.79e-05	0.000267	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOTCH1—breast cancer	2.76e-05	0.000264	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CG—breast cancer	2.73e-05	0.000261	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—APC—breast cancer	2.73e-05	0.000261	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—KIT—breast cancer	2.73e-05	0.000261	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—NOS3—breast cancer	2.71e-05	0.000259	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CG—breast cancer	2.7e-05	0.000258	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—APC—breast cancer	2.7e-05	0.000258	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—KIT—breast cancer	2.7e-05	0.000258	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EGF—breast cancer	2.7e-05	0.000258	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EGF—breast cancer	2.67e-05	0.000255	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—MAPK3—breast cancer	2.61e-05	0.00025	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—MAPK3—breast cancer	2.59e-05	0.000247	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—BRAF—breast cancer	2.56e-05	0.000245	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—BRAF—breast cancer	2.54e-05	0.000243	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CB—breast cancer	2.5e-05	0.000239	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IGF1—breast cancer	2.5e-05	0.000239	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AKT2—breast cancer	2.49e-05	0.000239	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—EGFR—breast cancer	2.48e-05	0.000238	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PTGS2—breast cancer	2.48e-05	0.000237	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IGF1—breast cancer	2.47e-05	0.000237	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AKT2—breast cancer	2.47e-05	0.000236	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—EGFR—breast cancer	2.46e-05	0.000235	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CD—breast cancer	2.4e-05	0.000229	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—PIK3CA—breast cancer	2.37e-05	0.000227	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CD—breast cancer	2.37e-05	0.000227	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SERPINE1—breast cancer	2.37e-05	0.000227	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—PIK3CA—breast cancer	2.35e-05	0.000225	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SERPINE1—breast cancer	2.35e-05	0.000225	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—KRAS—breast cancer	2.35e-05	0.000225	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—KRAS—breast cancer	2.32e-05	0.000222	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—NOS3—breast cancer	2.26e-05	0.000217	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—NOS3—breast cancer	2.24e-05	0.000214	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PTEN—breast cancer	2.16e-05	0.000207	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—PIK3CA—breast cancer	2.16e-05	0.000206	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MDM2—breast cancer	2.15e-05	0.000205	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—RAF1—breast cancer	2.14e-05	0.000205	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—PIK3CA—breast cancer	2.14e-05	0.000204	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—RELA—breast cancer	2.13e-05	0.000204	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MDM2—breast cancer	2.13e-05	0.000203	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—RAF1—breast cancer	2.12e-05	0.000203	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—ERBB2—breast cancer	2.12e-05	0.000203	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—RELA—breast cancer	2.11e-05	0.000202	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—ERBB2—breast cancer	2.1e-05	0.000201	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CB—breast cancer	2.09e-05	0.0002	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MTOR—breast cancer	2.09e-05	0.0002	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MTOR—breast cancer	2.07e-05	0.000198	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CB—breast cancer	2.07e-05	0.000198	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CXCL8—breast cancer	2.01e-05	0.000192	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—HRAS—breast cancer	1.99e-05	0.000191	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CXCL8—breast cancer	1.99e-05	0.00019	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—HRAS—breast cancer	1.98e-05	0.000189	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CDKN1B—breast cancer	1.96e-05	0.000188	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CDKN1B—breast cancer	1.94e-05	0.000186	CbGpPWpGaD
Bethanechol—CHRM3—GPCR downstream signaling—AKT1—breast cancer	1.94e-05	0.000186	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CASP3—breast cancer	1.92e-05	0.000184	CbGpPWpGaD
Bethanechol—CHRM2—GPCR downstream signaling—AKT1—breast cancer	1.92e-05	0.000184	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IL2—breast cancer	1.92e-05	0.000184	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—IL6—breast cancer	1.91e-05	0.000183	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CASP3—breast cancer	1.9e-05	0.000182	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IL2—breast cancer	1.9e-05	0.000182	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—IL6—breast cancer	1.89e-05	0.000181	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CCND1—breast cancer	1.87e-05	0.000179	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—JUN—breast cancer	1.87e-05	0.000179	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CCND1—breast cancer	1.85e-05	0.000177	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CTNNB1—breast cancer	1.85e-05	0.000177	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—JUN—breast cancer	1.85e-05	0.000177	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CTNNB1—breast cancer	1.83e-05	0.000175	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MMP9—breast cancer	1.82e-05	0.000174	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—CDKN1A—breast cancer	1.81e-05	0.000173	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PTEN—breast cancer	1.81e-05	0.000173	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MMP9—breast cancer	1.8e-05	0.000172	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—CDKN1A—breast cancer	1.79e-05	0.000171	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PTEN—breast cancer	1.79e-05	0.000171	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MAPK8—breast cancer	1.77e-05	0.000169	CbGpPWpGaD
Bethanechol—CHRM3—Signaling by GPCR—AKT1—breast cancer	1.76e-05	0.000168	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MAPK8—breast cancer	1.75e-05	0.000167	CbGpPWpGaD
Bethanechol—CHRM2—Signaling by GPCR—AKT1—breast cancer	1.74e-05	0.000167	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—SRC—breast cancer	1.67e-05	0.00016	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—SRC—breast cancer	1.66e-05	0.000159	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—VEGFA—breast cancer	1.63e-05	0.000156	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—VEGFA—breast cancer	1.61e-05	0.000154	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—STAT3—breast cancer	1.61e-05	0.000154	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—STAT3—breast cancer	1.6e-05	0.000153	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MAPK3—breast cancer	1.54e-05	0.000148	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MAPK3—breast cancer	1.53e-05	0.000146	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—PIK3CA—breast cancer	1.52e-05	0.000146	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—MYC—breast cancer	1.5e-05	0.000144	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TGFB1—breast cancer	1.5e-05	0.000143	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—MYC—breast cancer	1.49e-05	0.000142	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TGFB1—breast cancer	1.48e-05	0.000142	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—EGFR—breast cancer	1.47e-05	0.00014	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—EGFR—breast cancer	1.45e-05	0.000139	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—KRAS—breast cancer	1.39e-05	0.000133	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—KRAS—breast cancer	1.37e-05	0.000131	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—PIK3CA—breast cancer	1.27e-05	0.000122	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—PIK3CA—breast cancer	1.26e-05	0.000121	CbGpPWpGaD
Bethanechol—CHRM3—Metabolism—AKT1—breast cancer	1.24e-05	0.000119	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—TP53—breast cancer	1.23e-05	0.000118	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—TP53—breast cancer	1.22e-05	0.000117	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—HRAS—breast cancer	1.18e-05	0.000113	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—HRAS—breast cancer	1.17e-05	0.000112	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—IL6—breast cancer	1.13e-05	0.000108	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—IL6—breast cancer	1.12e-05	0.000107	CbGpPWpGaD
Bethanechol—CHRM3—Signaling Pathways—AKT1—breast cancer	1.04e-05	9.95e-05	CbGpPWpGaD
Bethanechol—CHRM2—Signaling Pathways—AKT1—breast cancer	1.03e-05	9.86e-05	CbGpPWpGaD
